Optimizerx Corp (OPRX) Stock Price, Quote & News

Company Profile

OptimizeRx Corporation operates as a digital healthcare technology company. It offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers' target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, limited distribu...

Industry: Health Information Services

Sector: Healthcare

Phone: 248 651 6568

Website: www.optimizerx.com

Address:

260 Charles Street, Suite 302, Waltham, United States

WOLFSTREET May. 23 at 8:24 PM

$OPRX had fun in the sun as a Biden beneficiary topping off at 99 bucks, I mean wow!, unfortunately $GDRX made its appearance when OPRX was fizzling out. Now it looks like the two are trying to meet at 3-4 range price wise. GDRX has not had it's BIG DAY in the sun YET, it is coming? Enjoy the double fist bump:

0 · Reply

WOLFSTREET May. 22 at 11:23 PM

$GDRX $OPRX Democrat embraces TRUMP RX, rather than remaining bitter competitors, both Mark Cuban Cost Plus Drugs and GoodRx now act as aggregator partners in broader discount initiatives like TrumpRx, which helps consumers shop around for the lowest possible out-of-pocket costs. Dominos keep falling... we should visit these tickers with CC, what do you think? Do they need a drive buy after FRIDAY Updates?

0 · Reply

DARKP00L May. 21 at 1:07 PM

$OPRX 07:31 on May. 21 2026 OptimizeRx's Electronic Health Record Network Integrated By DeepIntent #tradeideas

0 · Reply

focafoca99 May. 21 at 12:11 PM

$OPRX integrates its authenticated EHR network with DeepIntent DSP, the first healthcare DSP to do so.

0 · Reply

Trustfundkid69 May. 14 at 4:05 PM

$OPRX reversion to mean, let’s see it

0 · Reply

mryangstock May. 14 at 1:57 PM

$OPRX This is one of the stocks I had high hopes for that has disappointed me the most.

0 · Reply

anachartanalyst May. 13 at 5:02 PM

$OPRX https://anachart.com/wp-content/uploads/2026/05/1778691723_soc-img.jpg

0 · Reply

HappyStockholder May. 13 at 4:11 PM

$OPRX Glad I sold a while back, but I never expected the bloodbath to get this bad.

0 · Reply

Maissessap May. 13 at 1:44 PM

$OPRX Very well deserved drop ! Management bunch of liars.

0 · Reply

wtaf66 May. 13 at 12:33 PM

$OPRX swing pop!! Oh yeah…

0 · Reply

DeepIntent Becomes First Healthcare DSP to Integrate OptimizeRx's Authenticated EHR Network

2026-05-13T15:12:24.000Z - 11 days ago

OptimizeRx price target lowered to $11 from $20 at Lake Street

2026-05-13T14:04:14.000Z - 11 days ago

OptimizeRx price target lowered to $10 from $11 at B. Riley

2026-05-13T12:27:39.000Z - 11 days ago

OptimizeRx price target lowered to $7 from $10 at Stephens

2026-05-13T11:31:03.000Z - 11 days ago

OptimizeRx price target lowered to $14 from $17 at Stifel

May 12, 2026, 10:06 PM EDT - 12 days ago

OptimizeRx Q1 Earnings Call Highlights

2026-05-12T22:14:39.000Z - 12 days ago

OptimizeRx reports Q1 EPS 14c, consensus 0c

2026-05-12T22:07:44.000Z - 12 days ago

OptimizeRx cuts FY26 revenue view to $95M-$100M from $109M-$114M

May 12, 2026, 4:30 PM EDT - 12 days ago

OptimizeRx Earnings Call Transcript: Q1 2026

May 12, 2026, 4:30 PM EDT - 12 days ago

OptimizeRx Earnings release: Q1 2026

May 12, 2026, 4:30 PM EDT - 12 days ago

OptimizeRx Quarterly report: Q1 2026

May 12, 2026, 4:01 PM EDT - 12 days ago

OptimizeRx Reports First Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance

May 11, 2026, 7:30 AM EDT - 13 days ago

OptimizeRx Launches Programmatic Access to Authenticated EHR Advertising at Scale

Apr 30, 2026, 8:00 AM EDT - 24 days ago

OptimizeRx Proxy statement: Proxy filing

Apr 29, 2026, 4:05 PM EDT - 25 days ago

OptimizeRx Releases 2026 Environmental, Social, and Governance (ESG) Report

Apr 28, 2026, 8:00 AM EDT - 26 days ago

OptimizeRx Sets First Quarter 2026 Conference Call for May 12, 2026, at 4:30 p.m. ET

Apr 8, 2026, 4:05 PM EDT - 6 weeks ago

OptimizeRx Appoints Mary Varghese Presti to Board of Directors

Mar 17, 2026, 7:00 AM EDT - 2 months ago

OptimizeRx Slides: Corporate presentation

2026-03-06T14:46:41.000Z - 2 months ago

OptimizeRx trading resumes

2026-03-06T14:37:18.000Z - 2 months ago

OptimizeRx trading halted, volatility trading pause

2026-03-06T13:42:38.000Z - 2 months ago

OptimizeRx price target lowered to $20 from $24 at Lake Street

2026-03-06T13:36:56.000Z - 2 months ago

OptimizeRx price target lowered to $11 from $28 at B. Riley

2026-03-06T12:55:55.000Z - 2 months ago

OptimizeRx price target lowered to $18 from $32 at Roth Capital

2026-03-06T12:27:10.000Z - 2 months ago

OptimizeRx price target lowered to $17 from $21 at Stifel

2026-03-06T11:50:10.000Z - 2 months ago

OptimizeRx price target lowered to $10 from $17 at Stephens

Mar 5, 2026, 5:04 PM EST - 2 months ago

UPDATE – OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results

Mar 5, 2026, 4:30 PM EST - 2 months ago

OptimizeRx Earnings Call Transcript: Q4 2025

Mar 5, 2026, 4:30 PM EST - 2 months ago

OptimizeRx Annual report: Q4 2025

Mar 5, 2026, 4:30 PM EST - 2 months ago

OptimizeRx Earnings release: Q4 2025

2026-03-05T21:11:34.000Z - 2 months ago

OptimizeRx reports Q4 EPS 51c, consensus 22c

2026-03-05T21:11:02.000Z - 2 months ago

OptimizeRx sees FY26 revenue $109M-$114M, consensus $121.63M

2026-03-05T21:10:39.000Z - 2 months ago

OptimizeRx announces $10M share repurchase program

Mar 5, 2026, 4:01 PM EST - 2 months ago

OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results

2026-03-04T15:21:04.000Z - 2 months ago

OptimizeRx management to meet with Lake Street

Feb 5, 2026, 8:00 AM EST - 3 months ago

OptimizeRx Sets Fourth Quarter and Full Year 2025 Financial Results Conference Call for March 5, 2026, at 4:30 p.m. ET

2026-01-07T13:12:04.000Z - 4 months ago

OptimizeRx announces data collaboration with Experian

Jan 7, 2026, 8:00 AM EST - 4 months ago

OptimizeRx and Experian Collaborate to Improve Privacy-Safe Identity Resolution in Healthcare Marketing

2025-12-17T10:15:33.000Z - 5 months ago

OptimizeRx announces four new partner agreements

Dec 17, 2025, 4:30 AM EST - 5 months ago

OptimizeRx Continues Expansion of the Company's Point-Of-Care Network

2025-11-17T12:20:07.000Z - 6 months ago

OptimizeRx price target lowered to $17 from $20 at Stephens

Nov 6, 2025, 4:30 PM EST - 7 months ago

OptimizeRx Earnings Call Transcript: Q3 2025

Nov 6, 2025, 4:30 PM EST - 7 months ago

OptimizeRx Quarterly report: Q3 2025

Nov 6, 2025, 4:30 PM EST - 7 months ago

OptimizeRx Earnings release: Q3 2025

Nov 6, 2025, 4:01 PM EST - 7 months ago

OptimizeRx Reports Third Quarter 2025 Financial Results and Increases Fiscal Year 2025 Guidance

Oct 20, 2025, 8:00 AM EDT - 7 months ago

OptimizeRx Sets Third Quarter 2025 Conference Call for November 6, 2025, at 4:30 p.m. ET

Sep 10, 2025, 7:30 AM EDT - 9 months ago

OptimizeRx to Participate in the 9th Annual Lake Street Capital Best Ideas Growth Conference

Sep 9, 2025, 4:05 PM EDT - 9 months ago

OptimizeRx Partners with Lamar Advertising to Reach Clinically Relevant Audiences Through Out-of-Home Healthcare Advertising

Aug 19, 2025, 7:30 AM EDT - 9 months ago

OptimizeRx Corporation Announces Leadership Team Advancements to Accelerate Strategic Growth

Aug 7, 2025, 4:30 PM EDT - 10 months ago

OptimizeRx Earnings Call Transcript: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 10 months ago

OptimizeRx Quarterly report: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 10 months ago

OptimizeRx Earnings release: Q2 2025

Aug 7, 2025, 4:01 PM EDT - 10 months ago

OptimizeRx Reports Second Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance

Jul 17, 2025, 7:30 AM EDT - 11 months ago

OptimizeRx Sets Second Quarter 2025 Conference Call for August 7, 2025, at 4:30 p.m. ET

Jun 24, 2025, 7:30 AM EDT - 11 months ago

OptimizeRx Corporation Appoints CEO Steve Silvestro to Board of Directors

Jun 18, 2025, 3:00 AM EDT - 1 year ago

Simulmedia and OptimizeRx Announce Partnership from the Cannes Lions

May 16, 2025, 7:30 AM EDT - 1 year ago

OptimizeRx to Participate in Upcoming Investor Conferences

May 12, 2025, 4:30 PM EDT - 1 year ago

OptimizeRx Earnings Call Transcript: Q1 2025

May 12, 2025, 4:30 PM EDT - 1 year ago

OptimizeRx Quarterly report: Q1 2025

May 12, 2025, 4:30 PM EDT - 1 year ago

OptimizeRx Earnings release: Q1 2025

May 12, 2025, 4:05 PM EDT - 1 year ago

OptimizeRx Reports First Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance

May 1, 2025, 4:05 PM EDT - 1 year ago

OptimizeRx Releases 2025 Environmental, Social, and Governance (ESG) Report

Apr 30, 2025, 8:00 AM EDT - 1 year ago

OptimizeRx Proxy statement: Proxy Filing

Apr 23, 2025, 7:30 AM EDT - 1 year ago

OptimizeRx Sets First Quarter 2025 Conference Call for May 12, 2025, at 4:30 p.m. ET

Apr 18, 2025, 4:15 PM EDT - 1 year ago

OptimizeRx Corporation Announces Plan for Additional Board of Directors Refreshment

Mar 28, 2025, 8:00 AM EDT - 1 year ago

OptimizeRx Registration statement: Registration Filing

Mar 12, 2025, 8:30 AM EDT - 1 year ago

OptimizeRx Earnings Call Transcript: Q4 2024

Mar 12, 2025, 8:30 AM EDT - 1 year ago

OptimizeRx Annual report: Q4 2024

Mar 12, 2025, 8:30 AM EDT - 1 year ago

OptimizeRx Earnings release: Q4 2024

Mar 12, 2025, 7:30 AM EDT - 1 year ago

OptimizeRx Reports Strong Fourth Quarter and Full Year 2024 Financial Results

Mar 11, 2025, 8:00 AM EDT - 1 year ago

OptimizeRx Proxy statement: Proxy Filing

Mar 11, 2025, 7:30 AM EDT - 1 year ago

OptimizeRx Corporation Confirms Receipt of Notice of Director Nominations

Mar 10, 2025, 7:30 AM EDT - 1 year ago

OptimizeRx Corporation Appoints Stephen Silvestro as Chief Executive Officer

Feb 27, 2025, 7:30 AM EST - 1 year ago

OptimizeRx Sets Fourth Quarter and Full Year 2024 Financial Results Conference Call for March 12, 2025, at 8:30 a.m. ET

Dec 23, 2024, 8:45 AM EST - 1 year ago

OptimizeRx Announces Departure of CEO William Febbo and Appointment of Stephen Silvestro as Interim CEO

Nov 13, 2024, 4:30 PM EST - 1 year ago

OptimizeRx Earnings Call Transcript: Q3 2024

Nov 13, 2024, 4:30 PM EST - 1 year ago

OptimizeRx Quarterly report: Q3 2024

Nov 13, 2024, 4:30 PM EST - 1 year ago

OptimizeRx Earnings release: Q3 2024

Oct 31, 2024, 7:30 AM EDT - 1 year ago

OptimizeRx Sets Third Quarter 2024 Conference Call for November 13, 2024 at 4:30 p.m. ET

Sep 10, 2024, 7:30 AM EDT - 1 year ago

OptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a Multi-Brand, Multi-Solution Investment Commitment with Over $10M In-Year Total Value

Sep 9, 2024, 12:00 PM EDT - 1 year ago

OptimizeRx Launches Novel Brand Eligibility Technology, Enabling Dynamic Direct to Consumer Marketing for Healthcare Audiences

Aug 8, 2024, 4:30 PM EDT - 1 year ago

OptimizeRx Earnings Call Transcript: Q2 2024

Aug 8, 2024, 4:30 PM EDT - 1 year ago

OptimizeRx Quarterly report: Q2 2024

Aug 8, 2024, 4:30 PM EDT - 1 year ago

OptimizeRx Earnings release: Q2 2024

Jul 25, 2024, 7:30 AM EDT - 1 year ago

OptimizeRx Sets Second Quarter 2024 Conference Call for August 8, 2024 at 4:30 p.m. ET

Jul 23, 2024, 7:30 AM EDT - 1 year ago

OptimizeRx Delivers AI-Guided Privacy-Compliant Platform for Pharmaceutical Brand Marketing Amid Evolving Consumer Privacy Legislation

Jul 15, 2024, 7:30 AM EDT - 2 years ago

OptimizeRx Demonstrates Measurable Script Lift for a Major Depressive Disorder Brand Targeting Physicians of Hard-to-Reach Patients

Jun 20, 2024, 7:30 AM EDT - 2 years ago

New White Paper Highlights How Closing the Health Information Gap Between Doctors and Patients Improves Life Science Marketing & Adds Value to Clinical Conversations

May 14, 2024, 4:30 PM EDT - 2 years ago

OptimizeRx Earnings Call Transcript: Q1 2024

May 14, 2024, 4:30 PM EDT - 2 years ago

OptimizeRx Quarterly report: Q1 2024

May 14, 2024, 4:30 PM EDT - 2 years ago

OptimizeRx Earnings release: Q1 2024

May 14, 2024, 4:01 PM EDT - 2 years ago

OptimizeRx Reports First Quarter 2024 Financial Results

Apr 29, 2024, 8:00 AM EDT - 2 years ago

OptimizeRx Proxy statement: Proxy Filing

Apr 26, 2024, 7:30 AM EDT - 2 years ago

OptimizeRx Provides Business Update and Sets First Quarter 2024 Conference Call for May 14, 2024 at 4:30 p.m. ET

Apr 18, 2024, 7:30 AM EDT - 2 years ago

OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report

Apr 16, 2024, 7:00 AM EDT - 2 years ago

OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results

Apr 11, 2024, 7:30 AM EDT - 2 years ago

OptimizeRx Named America's Fastest-Growing Company for Fifth Year in a Row

Mar 28, 2024, 8:30 AM EDT - 2 years ago

OptimizeRx Earnings Call Transcript: Q4 2023

Mar 28, 2024, 8:30 AM EDT - 2 years ago

OptimizeRx Earnings release: Q4 2023

Mar 28, 2024, 8:30 AM EDT - 2 years ago

OptimizeRx Annual report: Q4 2023

Mar 25, 2024, 7:30 AM EDT - 2 years ago

OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ET

Mar 11, 2024, 4:30 PM EDT - 2 years ago

OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023

Mar 4, 2024, 3:51 PM EST - 2 years ago

OptimizeRx Powers Walmart's ‘Specialty Pharmacies of the Community' Outreach Effort

Jan 25, 2024, 7:30 AM EST - 2 years ago

OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape

Jan 9, 2024, 7:30 AM EST - 2 years ago

OptimizeRx Preannounces Select Expected 2023 Financials and Provides a Business Update

Dec 18, 2023, 7:30 AM EST - 2 years ago

OptimizeRx to Participate at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco

Nov 6, 2023, 8:30 AM EST - 2 years ago

OptimizeRx Earnings Call Transcript: Q3 2023

Nov 6, 2023, 8:30 AM EST - 2 years ago

OptimizeRx Quarterly report: Q3 2023

Nov 6, 2023, 8:30 AM EST - 2 years ago

OptimizeRx Earnings release: Q3 2023

Nov 6, 2023, 7:00 AM EST - 2 years ago

OptimizeRx Reports Third Quarter 2023 Financial Results

WOLFSTREET May. 23 at 8:24 PM

0 · Reply

WOLFSTREET May. 22 at 11:23 PM

0 · Reply

DARKP00L May. 21 at 1:07 PM

$OPRX 07:31 on May. 21 2026 OptimizeRx's Electronic Health Record Network Integrated By DeepIntent #tradeideas

0 · Reply

focafoca99 May. 21 at 12:11 PM

$OPRX integrates its authenticated EHR network with DeepIntent DSP, the first healthcare DSP to do so.

0 · Reply

Trustfundkid69 May. 14 at 4:05 PM

$OPRX reversion to mean, let’s see it

0 · Reply

mryangstock May. 14 at 1:57 PM

$OPRX This is one of the stocks I had high hopes for that has disappointed me the most.

0 · Reply

anachartanalyst May. 13 at 5:02 PM

$OPRX https://anachart.com/wp-content/uploads/2026/05/1778691723_soc-img.jpg

0 · Reply

HappyStockholder May. 13 at 4:11 PM

$OPRX Glad I sold a while back, but I never expected the bloodbath to get this bad.

0 · Reply

Maissessap May. 13 at 1:44 PM

$OPRX Very well deserved drop ! Management bunch of liars.

0 · Reply

wtaf66 May. 13 at 12:33 PM

$OPRX swing pop!! Oh yeah…

0 · Reply

MarketBeat May. 13 at 2:08 AM

https://marketbeat.com/a/8651228/ $OPRX OptimizeRx Q1 Earnings Call Highlights

0 · Reply

EarningsInsider May. 12 at 9:32 PM

https://www.marketbeat.com/earnings/reports/2026-5-12-optimizerx-co-stock/ $OPRX OptimizeRx Earnings Transcript

0 · Reply

Olivia_Strickland May. 12 at 9:09 PM

$OPRX down 7.73% AH after the Q1 print and a guidance update, because nothing says 'great quarter' like the company quietly rewriting the rest of the year a few hours later. already 53% in the hole YTD and the tape's still finding new lows to poke at. the real story isn't in the headline beat, it's in what they did to the outlook a few lines down. who actually read the release, what's the line that moved this? the guide miss the tape didn't like: https://tapeboard.com/chart/OPRX?utm_source=stocktwits&utm_medium=post&utm_campaign=olivia&utm_content=oprx-ah-dn-miss

0 · Reply

wtaf66 May. 12 at 8:45 PM

$OPRX when will I learn ….

0 · Reply

brd03 May. 12 at 8:14 PM

$OPRX earnings today??

0 · Reply

StocktwitsEarnings May. 12 at 8:14 PM

$OPRX Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.03 up 75.00% YoY • Reported revenue of $19.84M down -9.50% YoY • OptimizeRx updated its fiscal year 2026 guidance, now expecting revenue of $95M to $100M and adjusted EBITDA of $21M to $25M for the year.

0 · Reply

MuesLee May. 12 at 7:58 PM

$OPRX $RILY $SKLZ $VELO picked oprx

1 · Reply

MuesLee May. 12 at 7:40 PM

$VELO $RILY $SKLZ $OPRX What to buy out of these four before close ... undecided yet, expect each of them to bounce and revert.

0 · Reply

dailytarget500 May. 12 at 4:06 PM

$OPRX

0 · Reply

focafoca99 May. 11 at 11:57 AM

$OPRX debuted a programmatic EHR advertising platform, letting DSPs buy point‑of‑care media at scale.

0 · Reply

dailytarget500 Apr. 29 at 12:26 PM

$OPRX

0 · Reply

souldout Apr. 29 at 11:55 AM

$OMCL Six months since IPO, MedPal AI (MPAL) is starting to look like the UK’s most interesting healthcare growth story at £14m m/c This is a UK-based, AI-powered digital health company, with Wegovy and Mounjaro licences. https://medpal.clinic/weight-loss $OPRX $LFMD

0 · Reply

Market Cap	92.70M
Revenue (ttm)	109.43M
Net Income (ttm)	5.13M
EPS (ttm)	N/A
PE Ratio	7.06
Forward PE	9.88
Profit Margin	4.69%
Debt to Equity Ratio	0.18

Volume	340,900
Avg Vol	524,788
Day's Range	N/A - N/A
Shares Out	18.77M
Stochastic %K	19%
Beta	1.19
Analysts	Strong Sell
Price Target	$11.83